Comparative Pharmacology
Head-to-head clinical analysis: BILTRICIDE versus MINTEZOL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BILTRICIDE versus MINTEZOL.
BILTRICIDE vs MINTEZOL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Praziquantel increases the permeability of cell membranes to calcium ions in susceptible schistosomes and other trematodes, causing sustained contraction and paralysis of the worm musculature, leading to detachment from blood vessel walls and eventual death.
Thiabendazole inhibits the mitochondrial fumarate reductase system in susceptible helminths, disrupting energy metabolism.
60 mg/kg/day orally in 3 divided doses (20 mg/kg/dose) for 1 day.
50 mg/kg/day orally in 2-3 divided doses, maximum 3 g/day, for 2-3 days.
None Documented
None Documented
Terminal elimination half-life is approximately 0.8-1.5 hours for praziquantel; clinical significance: short half-life necessitates multiple dosing for sustained antiparasitic effect.
Terminal elimination half-life: 2-8 hours (mean 4 hours). Hepatic impairment prolongs; dose adjustment recommended.
Renal excretion accounts for approximately 80-90% of elimination, primarily as metabolites; biliary/fecal excretion is minor (<10%).
Renal: 90% within 24 hours (5% unchanged, 85% as metabolites). Fecal: <10%.
Category C
Category C
Anthelmintic
Anthelmintic